Date of Announcement: August 14, 115 Date of Statement: August 13, 115 Time of Statement: 7:00:03 Company Code: 6949 Company Name: Per Biotech - Innovation Subject: Announcement of change in par value of company shares from "NT$10" to "NT$0.5", Announcement Period: August 6, 115 to November 5, 115. Applicable Clause: Item 51 Factual Date: July 13, 115 Explanation: 1. Factual Date: July 13, 115 2. Company Name: Per Biotech Pharmaceutical Co., Ltd. 3. Relationship with Company (enter '本公司' or 'Subsidiary'):本公司 4. Cross-shareholding Ratio: Not applicable 5. Reason for Occurrence: (1) Approval Date / Factual Date of Par Value Change: July 13, 115 (2) Approval Document Number for Par Value Change: Ministry of Economic Affairs Commercial Division No. 11530095510 (3) Board Resolution Date Approving Share Exchange Plan: August 6, 115 (4) Par Value Before Change: NT$10.00 (5) Par Value After Change: NT$0.50 (6) Listing Date of New Shares and Delisting Date of Old Shares: September 7, 115 (7) Material Information Announcement Date for Share Reissuance: August 6, 115 (Material Information Announcement) 6. Countermeasures: None. 7. Other Matters to be Disclosed: One, the company has completed the procedure to change the par value of its shares from NT$10 to NT$0.5, which has been approved by the Taiwan Stock Exchange. Two, in conjunction with the par value change, the reference price on the first trading day of the new shares (September 7, 115) will be adjusted proportionally to one-twentieth of the closing price of the old shares on their last trading day (August 26, 115). Investors should take note. Three, after the par value change, metrics such as earnings per share, net asset value per share, and share price per unit will change. Please pay attention when reviewing information.

FACT BOX

  • Source: PR Times
  • Category: News